695 results on '"Tomasello,G"'
Search Results
2. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
- Author
-
Venturini, M, Abate, A, Pastorino, S, Canavese, G, Vecchio, C, Guenzi, M, Lambertini, M, Levaggi, A, Giraudi, S, Accortanzo, V, Floris, C.A., Aitini, E, Fornari, G, Miraglia, S, Buonfanti, G, Cherchi, M.C., Petrelli, F, Vaccaro, A, Magnolfi, E, Contu, A, Labianca, R, Parisi, A, Basurto, C, Cappuzzo, F, Merlano, M, Russo, S, Mansutti, M, Poletto, E, Nardi, M, Grasso, D, Fontana, A, Isa, L, Comandè, M, Cavanna, L, Iacobelli, S, Milani, S, Mustacchi, G, Venturini, S, Scinto, A.F., Sarobba, M.G., Pugliese, P, Bernardo, A, Pavese, I, Coccaro, M, Massidda, B, Ionta, M.T., Nuzzo, A, Laudadio, L, Chiantera, V, Dottori, R, Barduagni, M, Castiglione, F, Ciardiello, F, Tinessa, V, Ficorella, A, Moscetti, L, Vallini, I, Giardina, G, Silva, R, Montedoro, M, Seles, E, Morano, F, Cruciani, G, Adamo, V, Pancotti, A, Palmisani, V, Ruggeri, A, Cammilluzzi, E, Carrozza, F, D'Aprile, M, Brunetti, M, Gallotti, P, Chiesa, E, Testore, F, D'Arco, A, Ferro, A, Jirillo, A, Pezzoli, M, Scambia, G, Iacono, C, Masullo, P, Tomasello, G, Gandini, G, Zoboli, A, Bottero, C, Cazzaniga, M, Genua, G, Palazzo, S, D'Amico, M, Perrone, D, Del Mastro, Lucia, Poggio, Francesca, Blondeaux, Eva, De Placido, Sabino, Giuliano, Mario, Forestieri, Valeria, De Laurentiis, Michelino, Gravina, Adriano, Bisagni, Giancarlo, Rimanti, Anita, Turletti, Anna, Nisticò, Cecilia, Vaccaro, Angela, Cognetti, Francesco, Fabi, Alessandra, Gasparro, Simona, Garrone, Ornella, Alicicco, Maria Grazia, Urracci, Ylenia, Mansutti, Mauro, Poletti, Paola, Correale, Pierpaolo, Bighin, Claudia, Puglisi, Fabio, Montemurro, Filippo, Colantuoni, Giuseppe, Lambertini, Matteo, and Boni, Luca
- Published
- 2022
- Full Text
- View/download PDF
3. Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis
- Author
-
Tomasello, G., Gambini, D., Petrelli, F., Azzollini, J., Arcanà, C., Ghidini, M., Peissel, B., Manoukian, S., and Garrone, O.
- Published
- 2022
- Full Text
- View/download PDF
4. Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
- Author
-
Rossini, D., Boccaccino, A., Sbrana, A., Daniel, F., Borelli, B., Raimondi, A., Santini, D., Conca, V., Tomasello, G., Caponnetto, S., Marmorino, F., Zaniboni, A., Buonadonna, A., Masi, G., Lonardi, S., Pietrantonio, F., Falcone, A., Antonuzzo, A., and Cremolini, C.
- Published
- 2021
- Full Text
- View/download PDF
5. Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options
- Author
-
Grizzi G, Ghidini M, Botticelli A, Tomasello G, Ghidini A, Grossi F, Fusco N, Cabiddu M, Savio T, and Petrelli F
- Subjects
neoadjuvant endocrine therapy ,breast cancer ,cdk 4/6 inhibitors ,mtor inhibitors ,pi3k inhibitors ,aromatase inhibitors ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Giulia Grizzi,1 Michele Ghidini,2 Andrea Botticelli,3,4 Gianluca Tomasello,5 Antonio Ghidini,6 Francesco Grossi,2 Nicola Fusco,7,8 Mary Cabiddu,9 Tommaso Savio,10 Fausto Petrelli9 1Oncology Unit, Oncology Department, ASST of Cremona, Cremona, Italy; 2Oncology Unit, Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 3Medical Oncology Department, Sant’Andrea Hospital, Rome, Italy; 4Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy; 5Oncology Unit, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; 6Medical Oncology Unit, Casa Di Cura Igea, Milan, Italy; 7Division of Pathology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; 8Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy; 9Oncology Unit, Medical Sciences Department, ASST of Bergamo Ovest, Treviglio, Italy; 10Breast Unit, ASST of Bergamo Ovest, Treviglio, ItalyCorrespondence: Fausto PetrelliOncology Unit, Medical Sciences Department, ASST of Bergamo Ovest, Piazzale Ospedale 1, Bergamo 24047, Treviglio, ItalyTel +39 03 6342 4420Fax +39 03 6342 4380Email faupe@libero.itAbstract: Neoadjuvant hormonal therapy (NEO-HT) is a possible treatment option for breast cancer (BC) patient with estrogen receptor positive (ER+) and HER2 negative (HER2-) disease. The absence of solid data on the type of drugs to be used and duration of treatment as well as lack of clear evidence of effectiveness of NEO-HT compared to chemotherapy (CT) reserve its use for patients with old age or frail conditions. However, the low pathologic complete response rate (pCR) obtained with tamoxifen or aromatase inhibitors (AIs) alone does not make NEO-HT as a suitable option for the neoadjuvant treatment of HR+ HER2-. The use of the cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors palbociclib, ribociclib and abemaciclib of the mammalian target of rapamycin (mTOR) inhibitor everolimus and of the phosphoinositide 3 kinase (PI3K) inhibitor taselisib together with endocrine therapy (ET) has become a standard in advanced breast cancer, showing clinical effectiveness and significantly prolonging median progression-free survival compared to ET only. In the early phase disease, the use of ET together with CDK 4/6, mTOR and PI3K inhibitors is still investigational. Data from recent studies are promising even though less impressive than in metastatic setting. In this context, the use of genomic-transcriptomic tools (such as ONCOTYPE, PAM50) and the identification of novel biomarkers (ESR1, PI3Kca, PDGF-R) on tissue or with liquid biopsy could help to select patient prone to respond to endocrine-combined therapy and able to achieve pCR. With our review, we aimed at evaluating the current state of the art in the treatment of locally advanced breast cancer with NEO-HT.Keywords: neoadjuvant endocrine therapy, breast cancer, CDK 4/6 inhibitors, mTOR inhibitors, PI3K inhibitors, aromatase inhibitors
- Published
- 2020
6. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center: the Cremona experience
- Author
-
Ghidini, M., Donida, B. M., Totaro, L., Ratti, M., Pizzo, C., Benzoni, I., Lomiento, D., Aldighieri, F., Toppo, L., Ranieri, V., Senti, C., Tanzi, G., Martinotti, M., Passalacqua, R., Rovatti, M., and Tomasello, G.
- Published
- 2020
- Full Text
- View/download PDF
7. CORRELATION BETWEEN IBD, INTESTINAL DYSBIOSIS, DIET AND MOOD TONE DISEASE: ANALYSIS OF LITERATURE
- Author
-
Carini,F, Bressan,IN, La Palerma,I, Saguto,D, Zanghì,G, Mazzola,M, Galletta,C, Tomasello,G, Maida,G, Zanghì,M, Gaglio,R, Tomasello,G., Carini,F, Bressan,IN, La Palerma,I, Saguto,D, Zanghì,G, Mazzola,M, Galletta,C, Tomasello,G, Maida,G, Zanghì,M, Gaglio,R, and Tomasello,G.
- Subjects
Settore MED/18 - Chirurgia Generale ,Settore BIO/16 - Anatomia Umana ,Inflammatory Bowel Diseses, IBD, Dysbiosis, intestinal microbiome, mood tone - Abstract
This essay's main goal the present review is to highlight the connections between intestinal dysbiosis and the ensuing activation of the mucosal lymphatic system. One of the study's goals is to investigate the impact on mood caused by a serotonergic deficit driven by mucosal inflammation. It assesses the relationship between food consumption and the onset of psychological and mental illness as a secondary end aim. Patients with inflammatory bowel diseases and psychological and psychiatric mood disorders appear to benefit therapeutically from the sort of diet they consume.
- Published
- 2022
8. Biliary tract cancer: current challenges and future prospects
- Author
-
Ghidini M, Pizzo C, Botticelli A, Hahne JC, Passalacqua R, Tomasello G, and Petrelli F
- Subjects
biliary tract cancer ,cholangiocarcinoma ,adjuvant treatment ,first line treatment ,targeted therapies ,molecular profiling ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Michele Ghidini,1 Claudio Pizzo,1 Andrea Botticelli,2 Jens Claus Hahne,3 Rodolfo Passalacqua,1 Gianluca Tomasello,1 Fausto Petrelli4 1Department of Oncology, Azienda Socio Sanitaria Territoriale of Cremona, Cremona, Italy; 2Department of Clinical and Molecular Medicine, Sant’Andrea Hospital, Rome, Italy; 3Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey, UK; 4Department of Oncology, Operative Unit of Oncology, Azienda Socio Sanitaria Territoriale of Bergamo Ovest, Treviglio, Bergamo, Italy Purpose: Incidence and mortality of biliary tract carcinoma (BTC) are increasing, especially in South America and Asia. Such a disease often bears a dismal prognosis because of diagnosis occurring at late stages and for the frequent relapses after surgery. The aims of this review were to summarize the state of the art of the treatment of BTC and give a view at possible future prospects linked with molecular profiling, immunotherapy, and targeted therapies. Design: We conducted a systematic literature search using MEDLINE and the 2018 ASCO Meeting abstract databases to identify published clinical trials, translational series, and meeting abstracts. All significant papers and abstracts available to date were included. Results: For resected BTC, thanks to the BILCAP study, adjuvant chemotherapy (CT) with capecitabine should be regarded as the new standard of care. For locally advanced inoperable and metastatic diseases, the use of chemoradiotherapy and radioembolization has not been supported by any randomized Phase III study. The standard of care remains the combination of CT with gemcitabine and cisplatin, as reported by the ABC-02 trial. All targeted therapies have failed to improve the survival outcomes, either in combination with CT or as single agents and are not recommended in the treatment of BTC. Whole-exome sequencing and molecular profiling have helped in identifying genetic signatures typical of different BTC subtypes. With this support, new trials with targeted agents and immunotherapy have been designed, and results are awaited. Conclusion: BTC still remains a disease with very few treatment options. Different BTC subtypes own peculiar gene mutations and pathways alterations. Therefore, molecular profiling may be the only key to enable new tailored strategies with targeted agents and immunotherapy. Keywords: surgery, cholangiocarcinoma, adjuvant treatment, first-line treatment, targeted therapies, molecular profiling
- Published
- 2018
9. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
- Author
-
Dell’Aquila, E., Cremolini, C., Zeppola, T., Lonardi, S., Bergamo, F., Masi, G., Stellato, M., Marmorino, F., Schirripa, M., Urbano, F., Ronzoni, M., Tomasello, G., Zaniboni, A., Racca, P., Buonadonna, A., Allegrini, G., Fea, E., Di Donato, S., Chiara, S., Tonini, G., Tomcikova, D., Boni, L., Falcone, A., and Santini, D.
- Published
- 2018
- Full Text
- View/download PDF
10. Dissecting the genetic heterogeneity of gastric cancer
- Author
-
Hess, T., Maj, C., Gehlen, J., Borisov, O., Haas, S. L., Gockel, I., Vieth, M., Piessen, G., Alakus, H., Vashist, Y., Pereira, C., Knapp, M., Schuller, V., Quaas, A., Grabsch, H. I., Trautmann, J., Malecka-Wojciesko, E., Mokrowiecka, A., Speller, J., Mayr, A., Schroder, J., Hillmer, A. M., Heider, D., Lordick, F., Perez-Aisa, A., Campo, R., Espinel, J., Geijo, F., Thomson, C., Bujanda, L., Sopena, F., Lanas, A., Pellise, M., Pauligk, C., Goetze, T. O., Zelck, C., Reingruber, J., Hassanin, E., Elbe, P., Alsabeah, S., Lindblad, M., Nilsson, M., Kreuser, N., Thieme, R., Tavano, F., Pastorino, Roberta, Arzani, D., Persiani, Roberto, Jung, J. -O., Nienhuser, H., Ott, K., Schumann, R. R., Kumpf, O., Burock, S., Arndt, V., Jakubowska, A., Lawniczak, M., Moreno, V., Martin, V., Kogevinas, M., Pollan, M., Dabrowska, J., Salas, A., Cussenot, O., Boland-Auge, A., Daian, D., Deleuze, J. -F., Salvi, E., Teder-Laving, M., Tomasello, G., Ratti, M., Senti, C., De Re, V., Steffan, A., Holscher, A. H., Messerle, K., Bruns, C. J., Sivins, A., Bogdanova, I., Skieceviciene, J., Arstikyte, J., Moehler, M., Lang, H., Grimminger, P. P., Kruschewski, M., Vassos, N., Schildberg, C., Lingohr, P., Ridwelski, K., Lippert, H., Fricker, N., Krawitz, P., Hoffmann, Christian Pieter, Nothen, M. M., Veits, L., Izbicki, J. R., Mostowska, A., Martinon-Torres, F., Cusi, D., Adolfsson, R., Cancel-Tassin, G., Hoblinger, A., Rodermann, E., Ludwig, M., Keller, G., Metspalu, A., Brenner, H., Heller, J., Neef, M., Schepke, M., Dumoulin, F. L., Hamann, L., Cannizzaro, Rino, Ghidini, Maria Candida, Plassmann, D., Geppert, M., Malfertheiner, P., Gehlen, O., Skoczylas, T., Majewski, M., Lubinski, J., Palmieri, O., Boccia, Stefania, Latiano, A., Aragones, N., Schmidt, T., Dinis-Ribeiro, M., Medeiros, R., Al-Batran, S. -E., Leja, M., Kupcinskas, J., Garcia-Gonzalez, M. A., Venerito, M., Schumacher, J., Pastorino R. (ORCID:0000-0001-5013-0733), Persiani R. (ORCID:0000-0002-1537-5097), Hoffmann P., Cannizzaro R., Ghidini M., Boccia S. (ORCID:0000-0002-1864-749X), Hess, T., Maj, C., Gehlen, J., Borisov, O., Haas, S. L., Gockel, I., Vieth, M., Piessen, G., Alakus, H., Vashist, Y., Pereira, C., Knapp, M., Schuller, V., Quaas, A., Grabsch, H. I., Trautmann, J., Malecka-Wojciesko, E., Mokrowiecka, A., Speller, J., Mayr, A., Schroder, J., Hillmer, A. M., Heider, D., Lordick, F., Perez-Aisa, A., Campo, R., Espinel, J., Geijo, F., Thomson, C., Bujanda, L., Sopena, F., Lanas, A., Pellise, M., Pauligk, C., Goetze, T. O., Zelck, C., Reingruber, J., Hassanin, E., Elbe, P., Alsabeah, S., Lindblad, M., Nilsson, M., Kreuser, N., Thieme, R., Tavano, F., Pastorino, Roberta, Arzani, D., Persiani, Roberto, Jung, J. -O., Nienhuser, H., Ott, K., Schumann, R. R., Kumpf, O., Burock, S., Arndt, V., Jakubowska, A., Lawniczak, M., Moreno, V., Martin, V., Kogevinas, M., Pollan, M., Dabrowska, J., Salas, A., Cussenot, O., Boland-Auge, A., Daian, D., Deleuze, J. -F., Salvi, E., Teder-Laving, M., Tomasello, G., Ratti, M., Senti, C., De Re, V., Steffan, A., Holscher, A. H., Messerle, K., Bruns, C. J., Sivins, A., Bogdanova, I., Skieceviciene, J., Arstikyte, J., Moehler, M., Lang, H., Grimminger, P. P., Kruschewski, M., Vassos, N., Schildberg, C., Lingohr, P., Ridwelski, K., Lippert, H., Fricker, N., Krawitz, P., Hoffmann, Christian Pieter, Nothen, M. M., Veits, L., Izbicki, J. R., Mostowska, A., Martinon-Torres, F., Cusi, D., Adolfsson, R., Cancel-Tassin, G., Hoblinger, A., Rodermann, E., Ludwig, M., Keller, G., Metspalu, A., Brenner, H., Heller, J., Neef, M., Schepke, M., Dumoulin, F. L., Hamann, L., Cannizzaro, Rino, Ghidini, Maria Candida, Plassmann, D., Geppert, M., Malfertheiner, P., Gehlen, O., Skoczylas, T., Majewski, M., Lubinski, J., Palmieri, O., Boccia, Stefania, Latiano, A., Aragones, N., Schmidt, T., Dinis-Ribeiro, M., Medeiros, R., Al-Batran, S. -E., Leja, M., Kupcinskas, J., Garcia-Gonzalez, M. A., Venerito, M., Schumacher, J., Pastorino R. (ORCID:0000-0001-5013-0733), Persiani R. (ORCID:0000-0002-1537-5097), Hoffmann P., Cannizzaro R., Ghidini M., and Boccia S. (ORCID:0000-0002-1864-749X)
- Abstract
Background: Gastric cancer (GC) is clinically heterogenous according to location (cardia/non-cardia) and histopathology (diffuse/intestinal). We aimed to characterize the genetic risk architecture of GC according to its subtypes. Another aim was to examine whether cardia GC and oesophageal adenocarcinoma (OAC) and its precursor lesion Barrett's oesophagus (BO), which are all located at the gastro-oesophageal junction (GOJ), share polygenic risk architecture. Methods: We did a meta-analysis of ten European genome-wide association studies (GWAS) of GC and its subtypes. All patients had a histopathologically confirmed diagnosis of gastric adenocarcinoma. For the identification of risk genes among GWAS loci we did a transcriptome-wide association study (TWAS) and expression quantitative trait locus (eQTL) study from gastric corpus and antrum mucosa. To test whether cardia GC and OAC/BO share genetic aetiology we also used a European GWAS sample with OAC/BO. Findings: Our GWAS consisting of 5816 patients and 10,999 controls highlights the genetic heterogeneity of GC according to its subtypes. We newly identified two and replicated five GC risk loci, all of them with subtype-specific association. The gastric transcriptome data consisting of 361 corpus and 342 antrum mucosa samples revealed that an upregulated expression of MUC1, ANKRD50, PTGER4, and PSCA are plausible GC-pathomechanisms at four GWAS loci. At another risk locus, we found that the blood-group 0 exerts protective effects for non-cardia and diffuse GC, while blood-group A increases risk for both GC subtypes. Furthermore, our GWAS on cardia GC and OAC/BO (10,279 patients, 16,527 controls) showed that both cancer entities share genetic aetiology at the polygenic level and identified two new risk loci on the single-marker level. Interpretation: Our findings show that the pathophysiology of GC is genetically heterogenous according to location and histopathology. Moreover, our findings point to common molecular me
- Published
- 2023
11. FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
- Author
-
Cremolini, C., Loupakis, F., Masi, G., Lonardi, S., Granetto, C., Mancini, M.L., Chiara, S., Moretto, R., Rossini, D., Vitello, S., Allegrini, G., Tonini, G., Bergamo, F., Tomasello, G., Ronzoni, M., Buonadonna, A., Bustreo, S., Barbara, C., Boni, L., and Falcone, A.
- Published
- 2016
- Full Text
- View/download PDF
12. Circulating Tumor DNA (ctDNA) Dynamics and Clinical Outcome in Metastatic Colorectal Cancer (mCRC) Patients (pts) Undergoing Front-line Chemotherapy
- Author
-
Ghidini, M., Hahne, J. Claus, Senti, C., Tomasello, G., Ratti, M., Heide, T., Garrone, O., Cortellini, A., Passalacqua, R., and Valeri, N.
- Published
- 2023
- Full Text
- View/download PDF
13. Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy
- Author
-
Donida, B. M., Tomasello, G., Ghidini, M., Buffoli, F., Grassi, M., Liguigli, W., Maglietta, G., Pergola, L., Ratti, M., Sabadini, G., Toppo, L., Ungari, M., and Passalacqua, R.
- Published
- 2019
- Full Text
- View/download PDF
14. New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
- Author
-
Ghidini M, Hahne JC, Trevisani F, Panni S, Ratti M, Toppo L, and Tomasello G
- Subjects
Balugrastim / G-CSF / albumin / neutropenia / febrile neutropenia / pegfilgrastim ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Michele Ghidini,1 Jens Claus Hahne,2 Francesco Trevisani,3 Stefano Panni,1 Margherita Ratti,1 Laura Toppo,1 Gianluca Tomasello1 1Medical Department, Division of Oncology, ASST di Cremona, Ospedale di Cremona, Cremona, Italy; 2Division of Molecular Pathology, The Institute of Cancer Research, London and Sutton, UK; 3Department of Urology, Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, URI, Milan, Italy Abstract: Neutropenia and febrile neutropenia are two major complications of chemotherapy. Dose reductions, delays in treatment administration, and the use of granulocyte colony-stimulating factors are equally recommended options to preserve absolute neutrophil count in case of chemotherapy regimens bringing a risk of febrile neutropenia of 20% or higher. Recombinant granulocyte colony-stimulating factors, such as filgrastim and lenograstim, have a short elimination half-life (t1/2) and need to be used daily, while others, like pegfilgrastim and lipegfilgrastim, are characterized by a long t1/2 requiring only a single administration per cycle. Balugrastim is a novel long-acting recombinant granulocyte colony-stimulating factor obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Albumin binding increases the molecular weight and determines a high plasmatic stability leading to a t1/2 of ~19 days. Balugrastim’s efficacy, safety, and tolerability have been assessed in four different clinical trials involving breast cancer patients treated with doxorubicin and docetaxel. Pegfilgrastim was chosen as a comparator. Balugrastim was noninferior to pegfilgrastim with regard to the reduction of mean duration of severe neutropenia during cycle 1. Moreover, both treatments were comparable in terms of efficacy and safety profile. Balugrastim was well tolerated, with the only related adverse event being mild to moderate bone pain. The aim of this review is to summarize the currently available literature data on balugrastim. Keywords: G-CSF, granulocyte colony-stimulating factors, albumin, febrile neutropenia, pegfilgrastim
- Published
- 2016
15. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
- Author
-
Del Mastro, Lucia, primary, Poggio, Francesca, additional, Blondeaux, Eva, additional, De Placido, Sabino, additional, Giuliano, Mario, additional, Forestieri, Valeria, additional, De Laurentiis, Michelino, additional, Gravina, Adriano, additional, Bisagni, Giancarlo, additional, Rimanti, Anita, additional, Turletti, Anna, additional, Nisticò, Cecilia, additional, Vaccaro, Angela, additional, Cognetti, Francesco, additional, Fabi, Alessandra, additional, Gasparro, Simona, additional, Garrone, Ornella, additional, Alicicco, Maria Grazia, additional, Urracci, Ylenia, additional, Mansutti, Mauro, additional, Poletti, Paola, additional, Correale, Pierpaolo, additional, Bighin, Claudia, additional, Puglisi, Fabio, additional, Montemurro, Filippo, additional, Colantuoni, Giuseppe, additional, Lambertini, Matteo, additional, Boni, Luca, additional, Venturini, M, additional, Abate, A, additional, Pastorino, S, additional, Canavese, G, additional, Vecchio, C, additional, Guenzi, M, additional, Lambertini, M, additional, Levaggi, A, additional, Giraudi, S, additional, Accortanzo, V, additional, Floris, C.A., additional, Aitini, E, additional, Fornari, G, additional, Miraglia, S, additional, Buonfanti, G, additional, Cherchi, M.C., additional, Petrelli, F, additional, Vaccaro, A, additional, Magnolfi, E, additional, Contu, A, additional, Labianca, R, additional, Parisi, A, additional, Basurto, C, additional, Cappuzzo, F, additional, Merlano, M, additional, Russo, S, additional, Mansutti, M, additional, Poletto, E, additional, Nardi, M, additional, Grasso, D, additional, Fontana, A, additional, Isa, L, additional, Comandè, M, additional, Cavanna, L, additional, Iacobelli, S, additional, Milani, S, additional, Mustacchi, G, additional, Venturini, S, additional, Scinto, A.F., additional, Sarobba, M.G., additional, Pugliese, P, additional, Bernardo, A, additional, Pavese, I, additional, Coccaro, M, additional, Massidda, B, additional, Ionta, M.T., additional, Nuzzo, A, additional, Laudadio, L, additional, Chiantera, V, additional, Dottori, R, additional, Barduagni, M, additional, Castiglione, F, additional, Ciardiello, F, additional, Tinessa, V, additional, Ficorella, A, additional, Moscetti, L, additional, Vallini, I, additional, Giardina, G, additional, Silva, R, additional, Montedoro, M, additional, Seles, E, additional, Morano, F, additional, Cruciani, G, additional, Adamo, V, additional, Pancotti, A, additional, Palmisani, V, additional, Ruggeri, A, additional, Cammilluzzi, E, additional, Carrozza, F, additional, D'Aprile, M, additional, Brunetti, M, additional, Gallotti, P, additional, Chiesa, E, additional, Testore, F, additional, D'Arco, A, additional, Ferro, A, additional, Jirillo, A, additional, Pezzoli, M, additional, Scambia, G, additional, Iacono, C, additional, Masullo, P, additional, Tomasello, G, additional, Gandini, G, additional, Zoboli, A, additional, Bottero, C, additional, Cazzaniga, M, additional, Genua, G, additional, Palazzo, S, additional, D'Amico, M, additional, and Perrone, D, additional
- Published
- 2022
- Full Text
- View/download PDF
16. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
- Author
-
Floriani, I., Rulli, E., Cropalato Di Tullio, M., Poli, D., Galli, F., Biagioli, E., De Simone, I., Mangano, S., Tonato, M., Zucca, E., Valsecchi, M.G., Bajetta, E., Di Bartolomeo, M., Labianca, R., Amadori, D., Falcone, A., Di Costanzo, F., Daniele, B., Pinto, C., Comella, G., Nitti, D., Mini, E., De Placido, S., Marchet, A., Catena, L., Schiavo, M., Pinotti, G., Proserpio, I., Rosati, G., Bordonaro, R., Cordio, S., Burrafato, G., Bochicchio, A.M., Aieta, M., Fazio, N., Spada, F., Amoroso, V., Marini, G., Soto Parra, H., Novello, G., Massidda, B., Ionta, M.T., Comandè, M., Venezia, R., Bertolini, A., Menatti, E., Zanlorenzi, L., Colombo, A., Iop, A., Bonura, S., Mazza, E., Viganò, M., Ardizzoia, A., Dell'Oro, S., Lo Re, G., Santeufemia, D., Buonadonna, A., Luisi, D., Ucci, G., Di Lucca, G., Bonetti, A., Bergamo, F., Alù, M., Vastola, F., Marchetti, P., Corsi, D.C., Massa, E., Di Pinto, G., Duro, M., Oliani, C., Franchini, M., Inzoli, A., Gebbia, N., Repetto, L., Rota, S., Frontini, L., Mosconi, S., Quadri, A., De Grossi, S., Bidoli, P., Cazzaniga, M.E., Villa, F., Foa, P., Ferrari, D., Aitini, E., Rabbi, C., Barni, S., Petrelli, F., Giordano, M., Luchena, G., Pirovano, M., Nasisi, A., Catalano, V., Giordani, P., Zaniboni, A., Leone, F., Ferrario, S., Beretta, G.D., Menichetti, E.T., Conte, D., Mari, D., Giannicola, R., Pierantoni, C., Luporini, A.G., Ravaioli, A., Tassinari, D., Nicolini, M., Frassineti, G.L., Turci, D., Zumaglini, F., Tamberi, S., Piancastelli, A., Cruciani, G., Landi, L., Minuti, G., Cantore, M., Orlandi, M., Mambrini, A., Ciarlo, A., Cavaciocchi, D., Del Monte, F., Ricci, S., Brunetti, M.I., Lencioni, M., Sisani, M., Sozzi, P., Granetto, C., Chiara, S., Galetto, A.S., Ribecco, A.S., DeCensi, A., Ciuffreda, L., Baldini, E.E., Camisa, R., Todeschini, R., Santoro, A., Rimassa, L., Carnaghi, C., Pressiani, T., Boni, C., Rondini, E., Gnoni, R., Gasperoni, S., Cavanna, L., Palladino, M.A., Mattioli, R., Laici, G., Pucci, F., Alessio, M.D., Bernardini, I., Tomasello, G., Baldino, G., Rossetti, R., Giaquinta, S., Di Fabio, F., Rijas Llimpe, F.L., Brandes, A.A., Marzola, M., Montesarchio, V., Rea, A., Genua, G., Casaretti, R., Silvestro, L., Montano, M., Sarobba, M.G., Sanna, G., Filippelli, G., Dima, G., Greco, E., Roselli, M., Natale, D., Condemi, G., Fumi, G., Tafuto, S., Masullo, P., Tiberio, G., de Manzoni, G., Fiorentini, G., Mazzanti, R., Carlomagno, C., De Stefano, A., Cartenì, G., and Otero, M.
- Published
- 2014
- Full Text
- View/download PDF
17. INFLAMMATORY BOWEL DISEASE AND INFGERTILITY: ANALYSIS OF LITERATURE AND FUTURE PERSPECTIVES
- Author
-
Carini,F, Mazzola, M, Gagliardo,C, Scaglione, M, Giammanco,M, Tomasello,G, Carini,F, Mazzola, M, Gagliardo,C, Scaglione, M, Giammanco,M, and Tomasello,G
- Subjects
Inflammatory Bowel Diseases, IBD, Crohn's diseaase, Ulcerative Colitisi, male and female Infertility - Abstract
Background: inflammatory bowel diseases (IBD) are chronic disorders that affect the gastrointestinal tract but which also present extraintestinal manifestations. One of the problems related to IBD is the presence of bothfemale and male infertility. Aim: determine the correlation between IBD and male and female infertility by analyzing the literature. Material and method: studies carried out in the last twenty years have been selected through the PubMed search engine. Only studies were selected that in their conclusions showed a real correlation between IBD and infertility. Results: the first cause of infetility in both sexes is related to the surgical interventions that patients have to face during the course of the disease, but there are also psycological causes or causes related to the use of drugs used for therapy. Conclusions: further studies are needed to understand what are the real mechanism underlying infertility in subjects suffering from IBDS.
- Published
- 2021
18. Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioral tests
- Author
-
Gubinelli, F., primary, Cazzolla, G., additional, Negrini, M., additional, Kulacz, I., additional, Mehrdadian, A., additional, Tomasello, G., additional, Venuti, C., additional, Sarauskyte, L., additional, Jacobs, F., additional, Manfredsson, F.P., additional, Davidsson, M., additional, and Heuer, A., additional
- Published
- 2022
- Full Text
- View/download PDF
19. Revisiting the form finding techniques of Sergio Musmeci: The bridge over the Basento river
- Author
-
Magrone, P, primary, Tomasello, G, additional, Adriaenssens, S, additional, Gabriele, S, additional, and Varano, V, additional
- Published
- 2016
- Full Text
- View/download PDF
20. A rare case of perforated ileal diverticulitis in a young man: A case report and literature review
- Author
-
Provenzano,D, Zanghì,M, Rinzivillo,NM, Ciulla,A, Tomasello,G, Carini,F, Saguto,D, Zanghì G, Provenzano,D, Zanghì,M, Rinzivillo,NM, Ciulla,A, Tomasello,G, Carini,F, Saguto,D, and Zanghì G
- Subjects
Young man ,Intestinal resection ,Case report ,Emergency surgery ,Perforated ileal diverticulitis ,perforated ileal diverticulitis, intestinal resection, emergency surgery, acute abdomen - Abstract
Jejunoileal diverticulosis is a rare, often asymptomatic condition, consisting of acquired false diverticula. Diagnosis of ileal perforation is usually made incidentally or after complications, including obstruction, haemorrhage and diverticulitis. A previously healthy 17-year-old man presented to the Emergency Department with diffuse abdominal pain and fever. CT scan showed air-fluid level in the RLQ and free intraperitoneal air and fluid. The patient underwent an urgent exploratory laparotomy with an intestinal resection and primary anastomosis. We report a rare case of ileal perforation, due to diverticular disease in a healthy young man, treated an urgent surgery. Such an event requires immediate surgical intervention, especially if it presents as an acute abdomen. Although it can become a surgical emergency, jejunoileal diverticulosis remains underdiagnosed.
- Published
- 2021
21. Amyand’s hernia, an unknown entity that may cause surgeons difficulty: Our experience and literature review
- Author
-
Rinzivillo,MN, Zanghì,M, Marchi,D, Leanza,V, Saguto,D, Provenzano,D, Basile,F, Tomasello,G, Zanghì,GN, Rinzivillo,MN, Zanghì,M, Marchi,D, Leanza,V, Saguto,D, Provenzano,D, Basile,F, Tomasello,G, and Zanghì,GN
- Subjects
Amyand’s hernia ,Inguinal hernia ,Emergency surgery ,Appendix ,inguinal hernia, Amiand's ghernia, appendix, emergency surgery - Abstract
Amyand's hernia is an inguinal hernia, containing the appendix within the hernial sac. Claudius Amyand described the first clinical case in 1735. Despite the high incidence of inguinal canal hernia disease in the population with approximately 20 milion patients that undergo hernia repair annually, Amyand's hernia is a rare clinical conditions. It is characterized by an incidence of 1 % (0,19-1.7) and in 0,13 % of all cases, the appendix is inflamed. In this article, we will present our experience related to the treatment of a complicated Amyand's hernia, occasionally found during an emergency surgery for the repair of an incarcerated inguinal hernia. In addition, we will conduct a medical review of this pathology that often represents an unpleasant surprise for the surgeon.
- Published
- 2021
22. A BRIEF GUIDE TO THE ANATOMICAL DISSECTION OF THE STOMACH
- Author
-
Tomasello,G, Mazzola,M, Gagliardo,CM, Scaglione,S, Zannelli,C, Bellante,G, Fucarino,A, Pitruzzella,A, Rà,W, Mangano,GD, Giambalvo,F, Saguto,D, Marino Gammazza,A, Carini,F, Tomasello,G, Mazzola,M, Gagliardo,CM, Scaglione,S, Zannelli,C, Bellante,G, Fucarino,A, Pitruzzella,A, Rà,W, Mangano,GD, Giambalvo,F, Saguto,D, Marino Gammazza,A, and Carini,F
- Subjects
cadeveric study, abdomen stomach, dissection course, surgical anatomy - Abstract
The purpose of this article is to write a short guide on the macroscopic anatomy of the stomach, describing its structures, its relationships within the abdominal cavity and the dissection methods used during the internship performed by a group of students from the University of Palermo, Palermo, Italy, at the University of Malta, Msida, Malta, during the summer of 2018. Indeed,, they had the opportunity to spend a period of two weeks at the department of Anatomy in the Maltese University for studying and practining on some corpses, with the aim of improving their anatomical knowledge.
- Published
- 2021
23. A BRIEF DISSECTION GUIDE TO HUMAN THORAX
- Author
-
zannelli,C, Scaglione,M, Gagliardo,C, Mazzola,M, Saguto,D, Antonini,R, Canalella,V, Melita,A, Sferruzza,A, Rusignuolo,S, Tomasello G, Carini F, zannelli,C, Scaglione,M, Gagliardo,C, Mazzola,M, Saguto,D, Antonini,R, Canalella,V, Melita,A, Sferruzza,A, Rusignuolo,S, and Tomasello,G, Carini,F
- Subjects
human thorax, anatomical dissection guide - Abstract
The purpose of this technical report is to present that, in summer 2018, a group of students from the University of Palermo did at the University of malta. The students have the experience to dissected a thorax under a guide to expert dissectors. This work would be also a small dissection guide for young students who want to learn the main bases of dissection
- Published
- 2020
24. CT-GUIDED TRANSTHORACIC NEEDLE BIOPSY: ADVANTEGES IN HISTOPATHOLOGICAL AND MOLECULAR TESTS
- Author
-
Porrello,C, Gullo,R, Gagliardo,MC, Vaglica,A, Palazzolo,M, Giangregorio,F, Iadicola,D, Catanzaro,A, Scerrino,G, Lo Faso,F, carini,F, Tomasello,G, Porrello,C, Gullo,R, Gagliardo,MC, Vaglica,A, Palazzolo,M, Giangregorio,F, Iadicola,D, Catanzaro,A, Scerrino,G, Lo Faso,F, carini,F, and Tomasello,G
- Subjects
lung adenocarcinoma, lung nodule, molecular oncology, transthoracic needle biopsy - Abstract
Aim: The present study aimed to demonstrate that computed tomography-guided transthoracic needle biopsy (TTNB) is a safe procedure that gives a more accurate pre-operative tissue diagnosis for peripheral lung nodules than transthoracic needle aspiration, obtaining suitable samples for molecular test in lung adenocarcinomas. Patients and methods: Between December 2016 and March 2018 at Thoracic Surgery Department of the University of Palermo - Policlinico Paolo Giaccone Hospital, TTNB was performed in 42 patients with computed tomography-detected peripheral lung nodules > 10 mm, using 16-18 -Gauge tru-Cut needles. Results: With TTNB, we have estimated an accuracy for tissue diagnosis of 97,6%. At the molecular test, EGFR overexpression and ALK mutation resulted positive for 12/23 patients with lung adenocarcinoma. Conclusion: TTNB has showed a low rate of complications and it is adoptable as standard diagnostic procedure for peripheral lung nodules.
- Published
- 2020
25. A DISSECTION'S GUIDE TO HUMAN ABDOMINAL CAVITY
- Author
-
Scaglione,M, Zannelli,C, Antonini,R, Canalella,V, Melita,A, Rà,W, Rusignuolo,S, Sferruzza,A, Gagliardo,C, Guarrera,A, Lo Piccolo,C, Mazzola,M, Saguto,D, Carini,F, Tomasello,G, Scaglione,M, Zannelli,C, Antonini,R, Canalella,V, Melita,A, Rà,W, Rusignuolo,S, Sferruzza,A, Gagliardo,C, Guarrera,A, Lo Piccolo,C, Mazzola,M, Saguto,D, Carini,F, and Tomasello,G
- Subjects
surgical anatomical dissection guide, human cadaver lab, dissection course - Abstract
The purpose of this article is to show the abdominal cavity's dissection method. In the summer of 2018 a group of students from the University of Palermo, who had already taken the anatomy exam and had good knowledege of English, went for a period of two weeks to do a dissection course at the University of malta. The students dissected skin, subcutaneously, muscle layers, parietal peritoneum and abdominal organs. this works proves to be a small dissection guide for young medical students who want to learn the main bases of dissection and important information for topographical anatomy.
- Published
- 2020
26. ORAL MICROBIOTA: CHARACTERISTICS, RELATED PATHOLOGIES AND FUTURE PROSPECTS
- Author
-
Messina, M., Mazzola, M., francesco carini, Scardina, A. S., Tulone, L., Milazzo, V., Crapanzano, F., Gagliardo, C., Damiani, P., Tomasello, G., Messina,M, Mazzola,M, Carini,F, Scardina,A, Tulone,L, Milazzo,V, Crapanzano,F, Gagliardo,CM, Damiani,P, and Tomasello,G
- Subjects
oral microbiota, intestinal disbiosis - Abstract
The oral microbiota is represented by the set of bacteria and microrganisms that reside in the oral cavity. It is formed from bird and stabilizes during the period of permanent dentition. The oral microbiota poresents from 500 to 700 bacterial species, belonging to six main phyla, Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Spirochaetes and Fusobacteria. These bacteria partecipate in the formation of dental plaque, a sort of biofilm that deposits on the rigid surfaces of the oral cavity, and contributes to the healthy maintenance of the oral cavity. An alteration of the oral microbiota contributes to the pathogenesis of periodontitis, caries, gingivitis and also of systemic diseases such as cardiovascular disorders and problems in pregnancy.
- Published
- 2020
27. Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
- Author
-
Cremolini, C., Loupakis, F., Antoniotti, C., Lonardi, S., Masi, G., Salvatore, L., Cortesi, E., Tomasello, G., Spadi, R., Zaniboni, A., Tonini, G., Barone, C., Vitello, S., Longarini, R., Bonetti, A., DʼAmico, M., Di Donato, S., Granetto, C., Boni, L., and Falcone, A.
- Published
- 2015
- Full Text
- View/download PDF
28. PD-009 Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies
- Author
-
Casagrande, M., Moretto, R., Loupakis, F., Cremolini, C., Masi, G., Borelli, B., Lonardi, S., Marsico Valentina, A., Salvatore, L., Rossini, D., Ferrari, L., Ricci, V., Grande, R., Tomasello, G., Ronzoni, M., Allegrini, G., Tonini, G., Mancini, M., Zaniboni, A., Chiara, S., Carlomagno, C., and Falcone, A.
- Published
- 2016
- Full Text
- View/download PDF
29. P-027 Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy
- Author
-
Negri, F.V., Bozzetti, C., Azzoni, C., Bottarelli, L., Squadrilli, A., Pedrazzi, G., Lagrasta, C., Tamagnini, I., Bisagni, A., Porzio, R., Tomasello, G., Leonardi, F., Pinto, C., Ardizzoni, A., Sala, R., and Quaini, F.
- Published
- 2016
- Full Text
- View/download PDF
30. P-173 Outcomes of palliative gastrectomy in 549 asymptomatic patients with advanced gastric cancer
- Author
-
Fanotto, V., Fontanella, C., Cordio, S., Pasquini, G., Baretti, M., Filippi, R., Rosati, G., Santini, D., Giampieri, R., Di Donato, S., Tomasello, G., Brunetti, O., Caporale, M., Bergamo, F., Avallone, A., Scartozzi, M., Lutrino, S., Melisi, D., Antonuzzo, L., Pellegrino, A., and Aprile, G.
- Published
- 2016
- Full Text
- View/download PDF
31. SO-24 Circulating tumor DNA variant allelic fraction as a surrogate for disease burden estimation in patients with RAS wild-type metastatic colorectal cancer: A secondary endpoint of the VALENTINO study
- Author
-
Manca, P., primary, Corallo, S., additional, Lonardi, S., additional, Corti, F., additional, Antoniotti, C., additional, Procaccio, L., additional, Smiroldo, V., additional, Tomasello, G., additional, Murialdo, R., additional, Pagani, F., additional, Randon, G., additional, Martinetti, A., additional, Sottotetti, E., additional, Prisciandaro, M., additional, Ambrosini, M., additional, Raimondi, A., additional, Morano, F., additional, and Pietrantonio, F., additional
- Published
- 2021
- Full Text
- View/download PDF
32. 2326P Circulating tumor DNA (ctDNA) dynamics and clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) undergoing front-line chemotherapy
- Author
-
Ghidini, M., Hahne, J.C., Senti, C., Tomasello, G., Ratti, M., Heide, T., Garrone, O., Cortellini, A., Passalacqua, R., and Valeri, N.
- Published
- 2023
- Full Text
- View/download PDF
33. 343P Modulation of the immune system (ImS) during moderate physical activity (mPA) in breast cancer (BC) patients (pts) treated with neoadjuvant chemotherapy (NACT)
- Author
-
Garrone, O., Abbona, A., Paccagnella, M., Ruatta, F., Vanella, P., Tomasello, G., Barbin, F., Rossino, M.G., Croce, N., and Merlano, M.C.
- Published
- 2023
- Full Text
- View/download PDF
34. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
- Author
-
Bajetta, E., Floriani, I., Di Bartolomeo, M., Labianca, R., Falcone, A., Di Costanzo, F., Comella, G., Amadori, D., Pinto, C., Carlomagno, C., Nitti, D., Daniele, B., Mini, E., Poli, D., Santoro, A., Mosconi, S., Casaretti, R., Boni, C., Pinotti, G., Bidoli, P., Landi, L., Rosati, G., Ravaioli, A., Cantore, M., Di Fabio, F., Aitini, E., Marchet, A., Floriani, I., Rulli, E., Cropalato Di Tullio, M., Poli, D., Galli, F., Biagioli, E., De Simone, I., Poli, D., Mangano, S., Tonato, M., Zucca, E., Valsecchi, MG., Floriani, I., Bajetta, E., Di Bartolomeo, M., Labianca, R., Amadori, D., Falcone, A., Di Costanzo, F., Daniele, B., Pinto, C., Comella, G., Nitti, D., Mini, E., De Placido, S., Marchet, A., Bajetta, E., Di Bartolomeo, M., Catena, L., Schiavo, M., Pinotti, G., Proserpio, I., Rosati, G., Bordonaro, R., Cordio, S., Burrafato, G., Bochicchio, A.M., Aieta, M., Fazio, N., Spada, F., Amoroso, V., Marini, G., Soto Parra, H., Novello, G., Massidda, B., Ionta, M.T., Comandè, M., Venezia, R., Bertolini, A., Menatti, E., Zanlorenzi, L., Colombo, A., Iop, A., Bonura, S., Mazza, E., Viganò, M., Ardizzoia, A., DellʼOro, S., Lo Re, G., Santeufemia, D., Buonadonna, A., Luisi, D., Ucci, G., Di Lucca, G., Bonetti, A., Bergamo, F., Alù, M., Vastola, F., Marchetti, P., Corsi, D.C., Massa, E., Di Pinto, G., Duro, M., Oliani, C., Franchini, M., Inzoli, A., Gebbia, N., Repetto, L., Rota, S., Frontini, L., Labianca, R., Mosconi, S., Quadri, A., De Grossi, S., Bidoli, P., Cazzaniga, M.E., Villa, F., Foa, P., Ferrari, D., Aitini, E., Rabbi, C., Barni, S., Petrelli, F., Giordano, M., Luchena, G., Pirovano, M., Nasisi, A., Catalano, V., Giordani, P., Zaniboni, A., Leone, F., Ferrario, S., Beretta, G.D., Menichetti, E.T., Conte, D., Mari, D., Giannicola, R., Pierantoni, C., Luporini, A.G., Ravaioli, A., Tassinari, D., Nicolini, M., Amadori, D., Frassineti, G.L., Turci, D., Zumaglini, F., Tamberi, S., Piancastelli, A., Cruciani, G., Falcone, A., Landi, L., Minuti, G., Cantore, M., Orlandi, M., Mambrini, A., Ciarlo, A., Cavaciocchi, D., Del Monte, F., Ricci, S., Brunetti, M.I., Lencioni, M., Sisani, M., Sozzi, P., Granetto, C., Chiara, S., Galetto, A.S., Ribecco, A.S., DeCensi, A., Ciuffreda, L., Baldini, E.E., Camisa, R., Todeschini, R., Santoro, A., Rimassa, L., Carnaghi, C., Pressiani, T., Boni, C., Rondini, E., Gnoni, R., Di Costanzo, F., Gasperoni, S., Cavanna, L., Palladino, M.A., Mattioli, R., Laici, G., Pucci, F., Alessio, M.D., Bernardini, I., Tomasello, G., Baldino, G., Rossetti, R., Giaquinta, S., Pinto, C., Di Fabio, F., Rijas Llimpe, F.L., Brandes, A.A., Marzola, M., Montesarchio, V., Rea, A., Daniele, B., Genua, G., Casaretti, R., Silvestro, L., Montano, M., Sarobba, M.G., Sanna, G., Filippelli, G., Dima, G., Greco, E., Roselli, M., Natale, D., Condemi, G., Fumi, G., Tafuto, S., Masullo, P., Nitti, D., Marchet, A., Tiberio, G., de Manzoni, G., Fiorentini, G., Mazzanti, R., Carlomagno, C., De Stefano, A., Cartenì, G., and Otero, M.
- Published
- 2014
- Full Text
- View/download PDF
35. A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study
- Author
-
Loupakis F., Intini R., Cremolini C., Orlandi A., Sartore-Bianchi A., Pietrantonio F., Pella N., Spallanzani A., Dell'Aquila E., Scartozzi M., De Luca E., Rimassa L., Formica V., Leone F., Calvetti L., Aprile G., Antonuzzo L., Urbano F., Prenen H., Negri F., Di Donato S., Buonandi P., Tomasello G., Avallone A., Zustovich F., Moretto R., Antoniotti C., Salvatore L., Calegari M. A., Siena S., Morano F., Ongaro E., Cascinu S., Santini D., Ziranu P., Schirripa M., Buggin F., Prete A. A., Depetris I., Biason P., Lonardi S., Zagonel V., Fassan M., Di Maio M., Loupakis, F., Intini, R., Cremolini, C., Orlandi, A., Sartore-Bianchi, A., Pietrantonio, F., Pella, N., Spallanzani, A., Dell'Aquila, E., Scartozzi, M., De Luca, E., Rimassa, L., Formica, V., Leone, F., Calvetti, L., Aprile, G., Antonuzzo, L., Urbano, F., Prenen, H., Negri, F., Di Donato, S., Buonandi, P., Tomasello, G., Avallone, A., Zustovich, F., Moretto, R., Antoniotti, C., Salvatore, L., Calegari, M. A., Siena, S., Morano, F., Ongaro, E., Cascinu, S., Santini, D., Ziranu, P., Schirripa, M., Buggin, F., Prete, A. A., Depetris, I., Biason, P., Lonardi, S., Zagonel, V., Fassan, M., and Di Maio, M.
- Subjects
Adult ,Male ,Proto-Oncogene Proteins B-raf ,Scoring system ,DNA Mutational Analysis ,Metastases ,V600E ,BRAF ,Colorectal cancer ,Prognostic markers ,Risk Assessment ,Young Adult ,Predictive Value of Tests ,Risk Factors ,Biomarkers, Tumor ,Humans ,Genetic Predisposition to Disease ,Neoplasm Metastasis ,Aged ,Retrospective Studies ,Aged, 80 and over ,Middle Aged ,Prognosis ,Phenotype ,Italy ,Mutation ,Female ,Colorectal Neoplasms - Abstract
Background: Despite the well-known negative prognostic value of the V600EBRAF mutation in patients with metastatic colorectal cancer (mCRC), its outcome is quite heterogeneous, and the basis for this prognostic heterogeneity should be better defined. Methods: Two large retrospective series of V600EBRAF-mutated mCRC from 22 institutions served as an exploratory and validation set to develop a prognostic score. The model was internally and externally validated. Results: A total of 395 V600EBRAF-mutated mCRCs were included in the exploratory set. Performance status, CA19.9, lactate dehydrogenase, neutrophil/lymphocyte ratio, grading and liver, lung and nodal involvement emerged as independent prognostic factors for overall survival (OS). Two different scoring systems were built: a ‘complete’ score (0–16) including all significant covariates and a ‘simplified’ score (0–9), based only on clinicopathological covariates, and excluding laboratory values. Adopting the complete score, proportions of patients with a low (0–4), intermediate (5–8) and high (9–16) score were 44.7%, 42.6% and 12.6%, respectively. The median OS was 29.6, 15.5 (hazard ratio [HR] for intermediate vs low risk: 2.16, 95% confidence interval [CI]: 1.44–3.22, p < .001) and 6.6 months (HR for high vs low risk: 4.72, 95% CI: 2.72–8.20, p < .001). Similar results were observed also after adjusting for the type of first-line treatment and adopting the simplified score. The simplified prognostic score derived from the exploratory set was then applied to the validation set for external confirmation. Conclusions: These scoring systems are based on easy-to-collect data and defined specific subgroups with relevant differences in their life expectancy. These tools could be useful in clinical practice, would allow better stratification of patients in clinical trials and may be adopted for proper adjustments in exploratory translational analyses.
- Published
- 2019
36. A BRIEF DISSECTION'S GUIDE TO NORMAL MEDIASTINAL ANATOMY
- Author
-
CIPOLLA, Filippo, Fazio,B, Polisano,V, Sole,F, Spataro,B, Venezia,A, Marino Gammazza,A, Saguto,D, Pitruzzella,A, Mazzola,M, Guarrera,A, Nobile,S, Gagliardo,C, Lo Piccolo,C, Zammit,C, Porrello,C, Tomasello,G, Carini,F, Cipolla,F, Fazio,B, Polisano,V, Sole,F, Spataro,B, Venezia,A, Marino Gammazza,A, Saguto,D, Pitruzzella,A, Mazzola,M, Guarrera,A, Nobile,S, Gagliardo,C, Lo Piccolo,C, Zammit,C, Porrello,C, Tomasello,G, and Carini,F
- Subjects
Settore MED/18 - Chirurgia Generale ,Settore BIO/16 - Anatomia Umana ,DISSECTION COURSE, CADAVERIC STUDTY, MEDIASTINUM - Abstract
The purpose of this article is to show the mediastinal dissection method used during the stage performed by a group of students from the Univrersity of palermo that, during the sumer of 2017, had the opportunity to spend a period of 4 weeks at the Department of Anatomy of The University of malta. The students were guided to practice dissection of some corpes to study various mediastinal organs. This experience permitted to the students to verify practically what they lernt in the books, and reperesented a unique opportunity for them to perform practice with cadavers, that is actually very difficult to do in italian universities.
- Published
- 2019
37. Intestinal dysbiosis and hormonal neuroendocrine secretion in the fibromyalgic patient
- Author
-
Giovanni Tomasello, Vincenzo Bosco, Tomasello G, Provvidenza Damiani, Francesco Carini, Margherita Mazzola, and Emanuele Sinagra
- Subjects
musculoskeletal diseases ,Physiology ,lcsh:Medicine ,Intestinal dysbiosis ,cortisol ,General Biochemistry, Genetics and Molecular Biology ,Pathogenesis ,03 medical and health sciences ,0302 clinical medicine ,Fibromyalgia ,Vitamin D and neurology ,microbiota ,Medicine ,Secretion ,030203 arthritis & rheumatology ,hormones ,business.industry ,lcsh:R ,vitamin d ,dysbiosis ,medicine.disease ,humanities ,serotonin ,fibromyalgia ,Serotonin ,business ,Dysbiosis ,030217 neurology & neurosurgery ,Hormone - Abstract
Fibromyalgia is a rheumatic syndrome and its pathogenesis is controversial. The recent literature has placed considerable attention on the link between alteration of the intestinal microbiota and fibromyalgia, emphasizing the close connection between the neuroenteric system and the CNS. This study aims to evaluate the probable relationship between intestinal dysbiosis and altered secretion of hormones and vitamins such as cortisol, serotonin, Vitamin D and thyroid hormones in a patient with fibromyalgia.
- Published
- 2018
38. Colour Doppler-guided haemorrhoidal artery ligation: an adjunct in identification of haemorrhoidal vessels
- Author
-
Sammartano, A., Palumbo, V. D., Damiano, G., Spinelli, G., Allegra, A., Tomasello, G., and Lo Monte, A. I.
- Published
- 2013
- Full Text
- View/download PDF
39. RADIOPROTECTION IN 2018: AN UPDATE
- Author
-
Palumbo, Vincenzo D., Bruno, A., Di Trapani, B., Tomasini, S., Basile, A., Tomasello, G., Palumbo, Vincenzo D., Bruno, A., Di Trapani, B., Tomasini, S., Basile, A., and Tomasello, G.
- Subjects
minivasive procedure ,surgery ,Embolization ,Settore MED/18 - Chirurgia Generale ,interventional radiology ,minivasive procedures ,Settore MED/36 - Diagnostica Per Immagini E Radioterapia - Abstract
Fluoroscopically-guided interventional procedures are performed in large numbers in Europe and in the United States. Radiation doses received by interventional radiologists can vary for the same type of procedure and for similar patient doses. Occupational radiation protection is a necessity whenever radiation is used in the practice of medicine. The International Commission on Radiological Protection is engaging against occupational radiation damages, publishing regular recommendations on dose limits. These limits are expressed as effective doses for the whole body and also as equivalent doses for particular regions or tissues of practitioners’ bodies. Shielding and personal protective clothes are the most common tools for radiation protection employed up to now. Radiation protection is a dynamic field. It has undergone a significant evolutionary period during the past few decades and general improvement of protection techniques and technology is expected to continue. Further progress in the application of protection principles and concepts will contribute to balanced protection.
- Published
- 2018
40. A BRIEF ANATOMO-SURGICAL DISSECTION GUIDE TO HUMAN NECK: RESULTS OF THE COLLABORATION BETWEEN THE UNIVERSITY OF PALERMO AND THE UNIVERSITY OF MALTA
- Author
-
Carini,F, Salerno,M, Mazzola M, Lo Piccolo, C, Cavallo,G, MUSSO, Serafina, Gentile,S, D'Accardo,S, La Mantia, A, Accardo,A, Baldari,B, Besi,L, scopetti,M, Faleo,M, Zammit,C, Tomasello,G, Carini,F, Salerno,M, Mazzola,M, Lo Piccolo,C, Cavallo,G, Musso,S, Gentile,S, D'Accardo,S, La Mantia, A, Accardo,A, Baldari,B, Besi,L, scopetti,M, Faleo,M, Zammit,C, and Tomasello,G
- Subjects
Settore MED/18 - Chirurgia Generale ,Settore BIO/06 - Anatomia Comparata E Citologia ,surgical dissection cadaveric study, surgical dissection course, topographical anatomy - Abstract
The aim of this article is to show methods for dissection of the neck. In the summer of 2017 a group of students of the University of Palermo that have already passed the exam of Human Anatomy took a 4 weeks dissection course at the University of Malta. The students were provided with a dissection kit, video recording equipment and cameras for taking pictures. They dissected the skin, the subcutaneous tissue, the muscular bundles, the muscles, the vascular and nervous bundles, the nerves, the larynx, the trachea and the esophagus. This paper presents the results of the dissection course and a small and simple guide to young students and medical doctors who want to learn the bases of neck dissection.
- Published
- 2018
41. CLINICAL COURSE OF SEVERE COLITIS: A COMPARISON BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS
- Author
-
Sinagra,E, Orlando,A, Scalisi,A, Mocciaro F, Criscuoli V, Oliva,L, Maisano,S, Giunta,M, La Seta, F, Solina G, Rizzo AG, Leone,A, Tomasello,G, Cappello,F, Cottone,M, Sinagra,E, Orlando,A, Scalisi,A, Mocciaro,F, Criscuoli,V, Oliva,L, Maisano,S, Giunta,M, La Seta, F, Solina,G, Rizzo,AG, Leone,A, Tomasello,G, Cappello,F, and Cottone,M
- Subjects
Adult ,Male ,Settore MED/18 - Chirurgia Generale ,Settore MED/12 - Gastroenterologia ,Crohn Disease ,Humans ,Colitis, Ulcerative ,Female ,colectomy, Crohn's diesease, ulcerative colitis ,Middle Aged - Abstract
Few data are available about the clinical course of severe colonic Crohns disease (CD). The aim of this study is to describe the clinical course of severe Crohns colitis in a patient cohort with isolated colonic or ileocolonic CD, and to compare it with the clinical course of patients with severe ulcerative colitis (UC). Thirty-four patients with severe Crohns colitis were prospectively identified in our cohort of 593 consecutive hospitalized patients through evaluation of the Crohns Disease Activity Index score and the Harvey-Bradshaw Index. One hundred sixty-nine patients with severe ulcerative colitis were prospectively identified in our cohort of 449 consecutive hospitalized patients through evaluation of the Lichtiger score and the Truelove-Witts score. We evaluated the following data/aspects: response to steroids, response to biologics, colectomy rate in acute, colectomy rate during follow-up, megacolon and cytomegalovirus infection rate. We did not find significant differences in the response to steroids and to biologics, in the percentage of cytomegalovirus infection and of megacolon, while the rate of colectomy in acute turned out to be greater in patients with severe Crohns colitis compared to patients with severe UC, and this difference appeared to be the limit of statistical significance (Chi-squared 3.31, p = 0.069, OR 0.39); the difference between the colectomy rates at the end of the follow-up was also not significant. In the whole population, by univariate analysis, according to the linear regression model, a young age at diagnosis is associated with a higher overall colectomy rate (p = 0.024) and a higher elective colectomy rate (p = 0.022), but not with a higher acute colectomy rate, and an elevated ESR is correlated with a higher overall colectomy rate (p = 0.014) and a higher acute colectomy rate (p = 0.032), but not with a higher elective colectomy rate. This correlation was significant on multivariate analysis. The overall rate of colectomy in the cohort of patients with severe Crohns colitis was greater than that of the cohort of patients with severe UC, but this figure is not supported by a different clinical response to steroid therapy or rescue therapy with biologics. The clinical course of severe Crohns colitis requires to be clarified by prospective studies that include a larger number of patients in this subgroup of disease.
- Published
- 2018
42. LYCOPENE AND PROSTATE CANCER: AN OVERVIEW
- Author
-
Carini F, Zeenny MN, MAZZOLA, ANNA MARIA, Di Trapani,B, ACCARDO PALUMBO, Vincenzo, Gerges Geahìgea A, Sinagra,E, Leone,A, Tomasello,G, Carini,F, Zeenny,MN, Mazzola,M, Di Trapani,B, Palumbo,V, Gerges Geahìgea A, Sinagra,E, Leone,A, and Tomasello,G
- Subjects
prostate cancer, antioxidants, lycopene - Abstract
Prostate cancer is one of the most common cancers in the world. Its pathogenesis is multifactorial and is linked to risk factors such as age, diet, cigarette smoking, family history and the onset of oxidative stress. In recent times, therefore, we are investigating the use of antioxidants as a primary and tertuary prevention of prostate cancer. Numerous studies in the literature focused on lycopene, a molecule belonging to the family of carotenoids that is commonly foud in tomatoes and products derived from it. The literature analyzed in the last two years shows how lycopene inhibits different mecchanism linked to carcinogenesis and tumor progression. However, there are still many points to be clarified the real antitumoral capacity of this substance.
- Published
- 2018
43. Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
- Author
-
Verderame, F., Russo, A., Leo, R. Di, Badalamenti, G., Santangelo, D., Cicero, G., Valerio, M. R., Gulotta, G., Tomasello, G., Gebbia, N., and Fulfaro, F.
- Published
- 2006
44. 267P AB-ITALY: The impact of drug-drug interaction on abemaciclib treatment in Italian real world experience
- Author
-
Botticelli, A., Scagnoli, S., Pisegna, S., Toss, A., Fabi, A., Criscitiello, C., D'Auria, G., Fabbri, M.A., Orlandi, A., Barberi, V., Caputo, R., Vici, P., Palleschi, M., Santini, D., Tomasello, G., Ricevuto, E., M. Simmaco, Preissner, R., Cortesi, E., and Marchetti, P.
- Published
- 2022
- Full Text
- View/download PDF
45. Helicobacter pylori and Barretts esophagus: a protective factor or a real cause?
- Author
-
Tomasello, G., Giordano, F., Mazzola, M., Jurjus, A., Jurjus, R., Damiani, P., Nobile, S., Carini, F., Leone, A., Tomasello,G, Giordano,F, Mazzola,M, Jurjus,A, Jurjus,R, Damiani,P, Nobile,S, Carini,F, and Leone,A
- Subjects
Settore MED/12 - Gastroenterologia ,Esophageal Neoplasms ,Helicobacter pylori ,Stomach ,Adenocarcinoma ,Hydrogen-Ion Concentration ,Protective Factors ,Helicobacter Infections ,Settore MED/18 - Chirurgia Generale ,Barrett Esophagus ,Esophagus ,esophageal cancer, Barrett's esophagous, pre-cancerosis, Helycoabter Pylori Infection ,Risk Factors ,Gastroesophageal Reflux ,Humans - Abstract
Nothwithstanding the definite aethiopathogenetic path of certain diseases, the relationship between Helicobacter Pylori (H. Pylori) and barrett's esophagus (BE), a condition that increases the risk for dysplasia and consequently adenocarcinoma of the distal esophagus and esophagogastric junction, remains uncertain. this paper reviews the current scientific literature with emphasis on the protective correlation between H. Pylori infection and BE, and demonstrates that a causal relathionship has not been disproved with certainty. Furthermore, H. Pylori infection could pose a risk for the onset of gastroesophageal reflux disease (GERD), which could in turn trigger BE, a precancerous lesion and subsequently cause cancer. by analyzing the current available data, this article tries to verify that H. Pylori infection is the underlying cause of esophageal cancer.
- Published
- 2017
46. THE FINGERPRINT OF THE HUMAN GASTROINTESTINAL TRACT MICROBIOTA: A HYPOTHESIS OF MOLECULAR MAPPING
- Author
-
Tomasello, G., Mazzola, M., Jurjus, A., Cappello, F., francesco carini, Damiani, P., Gerges Geagea, A., Zeenny, M. N., Leone, A., Tomasello, G., Mazzola, M., Jurjus, A., Cappello, F., Carini, F., Damiani, P., Geagea Gerges, A., Zeenny, M., and Leone, A.
- Subjects
Settore MED/12 - Gastroenterologia ,gastrointestinal tract microbiota, dysbiosis, Inflammatory Bowel Diseases, molecular mapping, fingerprint ,Inflammatory Bowel Diseases ,DNA Fingerprinting ,Anti-Bacterial Agents ,Bacterial Typing Techniques ,Gastrointestinal Microbiome ,Gastrointestinal Tract ,Settore MED/18 - Chirurgia Generale ,RNA, Ribosomal, 16S ,DNA Barcoding, Taxonomic ,Dysbiosis ,Homeostasis ,Humans ,Molecular Targeted Therapy ,Precision Medicine ,Oligonucleotide Array Sequence Analysis - Abstract
The precise etiology of Inflammatory Bowel Disease (IDB) remains unclear and several factors are believed to play a role in its development and progression, including the composition of microbial communities resident in the gastrointestinal tract. Human intestinal microbiota are extensive with at least 15,000-36,000 bacterial species. However, thanks to the new development in sequencing and molecular taxonomic methodologies, our understanding of the microbiota population composition, dynamics, and ecology has greatly increased. Intestinal microbiota play a critical role in the maintenance of the host intestinal barrier homeostasis, while dysbiosis, which involves reduction in the microbiome diversity, can lead to progression of inflammatory disorders, such as IBD and colorectal cancer. It is hypothesized that fingerprinting characterization of the microbiota community composition is the first step in the study of this complex bacterial ecosystem and a crucial step in the targeted therapy. Molecular fingerprinting of human gastrointestinal tract microbiota could be performed by different techniques including the semi quantitation, 16SrRNA, the DNA- microarray as well as other relatively new methods which were developed to study many complex bacterial ecosystems. These techniques provide individual data and profiles, using fast and sensitive tools for the high taxonomic level fingerprint of the human intestinal microbiota and provide estimation of the relative presence of the microbial target groups within each individual. Such personalized information serves as a remarkable and unprecedented opportunity to improve targeted medical treatment and probably develop strategies to prevent disease.
- Published
- 2017
47. 2016 WHO GLOBAL GUIDELINES FOR THE PREVENTION OF SURGICAL SITE INFECTION: A NEW STEP TO IMPROVE PATIENT'S SAFETY BEFORE, DURING AND AFTER SURGERY
- Author
-
Palumbo, V., Bruno, A., Di Trapani, B., Tomasello, G., Palumbo,VD, Bruno, A, Di Trapani,B, and Tomasello, G
- Subjects
Settore MED/18 - Chirurgia Generale ,wound surgical infections, guidelines, patient safety - Abstract
Surgical site infection (SSI) are among the most preventable health-care-associated infections and are a substantial burden to health-care systems and service payers worldwide in terms of patient morbidity, mortality, and additional costs. SSI prevention is complex and requires the integration of a range of measures before, during and after surgery. No international guidelines are available and incosistencies in the interpretations of evidence and recommendations of national guidelines have been identified. Given the burden of SSI worldwide, the numerous gaps in evidence-based guidance, and the need for standardisation and a global approach, WHO decided to prioritise the development of evidence-based recommendations for thew prevention of SSI. The guidelines take into account the balance between benefits and harms, the evidence quality, costs and resource use implications, and patgients values andf preferences. on the basis of systematic literature reviews and expert consensus, we present 23 recommendations on preoperative, intraoperative and postoperative preventive measures. The WHO recommendations were developed with a global perspective and they take into account the balance between benefitgs and harms, the evidence quality level, cost and resource use implications, and patient values and preferences.
- Published
- 2017
48. Experiences that 'reach the heart'. Taking part in a whole body dissection course at the University of Malta
- Author
-
Pollara, P., Inzerauto, M., Ravì, N., Tomasino, C., Scorsone, A., Liguoro, B., Busardò, F., Slama, F., Capitummino, R., Seidita, E., Tomasello, G., Carini, F., Pomara, C., Pollara, P., Inzerauto, M., Ravì, N., Tomasino, C., Scorsone, A., Liguoro, B., Busardò, F., Slama, F., Capitummino, R., Seidita, E., Tomasello, G., Carini, F., and Pomara, C.
- Subjects
Settore MED/18 - Chirurgia Generale ,Coronary arteries ,Settore BIO/16 - Anatomia Umana ,Medicine (all) ,Heart dissection ,Whole body dissection course ,Coronary arterie ,anatomical dissection course, heart dissection - Abstract
This article summarizes the activities of the four-week whole body dissection course the main authors participated in in August 2016 at the dissection hall of the University of Malta (UoM). Our team comprised 10 second-year medicine students from University of Palermo chosen among who had passed the Human Anatomy exam brilliantly. The need to move to the UoM to take part in such activity derives from the lack of practice approach in Italian schools of medicine, focused mostly on the theoretical studies, neglecting practical experience. The heart dissection reveal itself as a huge opportunity to finally apply our anatomical knowledge, improving it and enabling us to compare images took from books to the actual organ. We had the chance to handle a real heart, to appreciate its weight and consistence. We took part in coronary artery courses focusing on their functions within the heart machinery. This article summarizes the activities of the four-week whole body dissection course the main authors partecipated in August 2016 at the dissection hall of the University of Malta (UoM). Our team comprised 10 second-year medicine students from University of Palermo chosen among who had passed the Human Anatomy exam brilliantly. The need to molve to the UoM to take part in such activity derives from the lack of practice approach in Italian schools of medicine, focused mostly on the theoretical studies, neglecting practical experience. The heart dissection reveal itself as a huge opportunity to finally apply our anatomical knowledge, improving it and enabling us to compare image took from books to the actual organ. We had the chance to handle a real heart, to appreciate its weight and consistence. We took part in coronary artery courses focusing on their functions within the heart machinery.
- Published
- 2017
49. FOCAL ACTIVE COLITIS AS A PREDICTOR OF INFLAMMATORY BOWEL DISEASE: RESULTS FROM A SINGLE-CENTER EXPERIENCE
- Author
-
Sinagra, E., Raimondo, D., Pompei, G., Fusco, G., Rossi, F., Tomasello, G., Leone, A., Francesco Cappello, Morreale, G. C., Midiri, F., Midiri, M., Rizzo, A. G., SINAGRA, E, RAIMONDO, D, POMPEI, G, FUSCO, G, ROSSI, F, TOMASELLO, G, LEONE, A, CAPPELLO, F, MORREALE, GC, MIDIRI, F, MIDIRI, M, and RIZZO, AG
- Subjects
Adult ,Aged, 80 and over ,Male ,Academic Medical Centers ,Incidental Findings ,Settore MED/12 - Gastroenterologia ,Colon ,Settore BIO/16 - Anatomia Umana ,Colonoscopy ,Middle Aged ,Colitis ,Inflammatory Bowel Diseases ,Prognosis ,Diagnosis, Differential ,Italy ,Disease Progression ,Humans ,Female ,focal colitis, inflammatory bowel diseases, colon microbiota, dysbiosis ,Prospective Studies ,Intestinal Mucosa ,Aged ,Retrospective Studies - Abstract
The term focal active colitis (FAC) is conventionally used to describe the presence of isolated cryptitis, characterized by an inflammatory infiltrate consisting of intraepithelial neutrophils and/or neutrophils invading the lumen of the criptae, with no other microscopic alteration of the colonic mucosa and, in particular, without the presence of signs of chronic inflammation. To date, only four studies, including one conducted in a pediatric population, have been performed to evaluate the clinical significance of this disease. The aim of this retrospective study on prospectively-collected data is to evaluate the clinical implications of the focal active colitis, since there still remains a marked uncertainty regarding this topic and about how often such a diagnosis will presage a diagnosis of inflammatory bowel disease (IBD). Clinical, endoscopic, and pathological data were retrospectively reviewed from 30 patients with focal active colitis, who had no other diagnostic findings on colorectal biopsy and no history of chronic inflammatory bowel disease. The histological findings were correlated with clinical diagnoses. Thirty patients (11 males, 19 females; age 24-80 years, median 56 years) (0.5%) out of 5,600 undergoing colonoscopy between January 2012 and December 2016 presented a definitive diagnosis of FAC. Follow-up ranged from 6 to 60 months (median 24 months). At endoscopy, 19 patients (63%) had mild and non-specific changes, such as mild mucosal erythema, while 11 (37%) had normal findings. Eight patients were documented as having irritable bowel syndrome, while nine cases could be attributed to the effects of drugs, five presented FAC as incidental finding, one a diagnosis of infectious colitis, and seven a diagnosis of IBD (4 with Crohns disease). FAC was confirmed to be a more significant predictor of IBD than the previous literature would indicate, even if larger prospective studies, targeted to study this relationship, are needed to understand more clearly its clinical significance.
- Published
- 2017
50. DYSBIOSIS, INFLAMMATORY BOWEL DISEASE AND COLON CANCER: THERE IS A CORRELATION?
- Author
-
Tomasello, G., Damiani, P., Aldo Gerbino, Angelo Leone, Giovanni Tomasello, Provvidenza Damiani, Tomasello,G, and Damiani,P
- Subjects
Settore MED/18 - Chirurgia Generale ,Inflammatory Bowel Disease, IBD, colon cancer - Abstract
Dysbiosis has been linked to IBD. The intestinal microbiota plays a fundamental role in health and the progression of diseases such as IBD and CRC. Many cancers arise from sites of infection and chronic inflammation. Patients with inflammatory Bowel Disease (IBD) have an increased risk of 10%-15% developing colorectal cancer. Therefore, a complete understanding of the composition and function of the gut microbiota is critical.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.